We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of BSTC yet.

BSTC Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2021, worth a combined $0 — down 100% from $204K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BSTC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was UBS AM, exiting entirely with an estimated $204K sold.

  • 0 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2021, down from 1 in Q4 2020.
  • Funds reported $0 of BioSpecifics Technologies Corp. stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new BioSpecifics Technologies Corp. positions in Q1 2021 and 1 closed out, a net change of -1 holder.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2021 was UBS AM, an estimated $204K sold.

Based on aggregated 13F filings for Q1 2021.